Compare Becton Dickinson and Co (BDX) vs VanEck JP Morgan EM Local Currency Bond ETF (EMLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.6. The key difference: Becton Dickinson and Co pays a 2.34% dividend while VanEck JP Morgan EM Local Currency Bond ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| BDX | EMLC | |
|---|---|---|
Market Cap | $48.93B | — |
Sector | Health | Fixed Income |
52-Week High | $185.39 | $26.59 |
52-Week Low | $138.62 | $24.83 |
Enterprise Value | $65.03B | — |
Dividend Yield | 2.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
EMLC trades at $25.72, up 0.67% today, with a bullish technical signal driven by moving averages. Recent dividends include $0.14 paid in June 2026. The stock shows strong momentum indicators, though RSI levels suggest potential overbought conditions near-term.
Outlook remains positive given technical strength and dividend yield, but limited fundamental data availability warrants caution. Risks include emerging market volatility and Fed policy sensitivity. Analyst sentiment leans bullish, but investors should seek updated financial disclosures for full assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →
